These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23218901)

  • 1. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
    Y-Hassan S; Tornvall P; Törnerud M; Henareh L
    Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of cardiogenic shock caused by capecitabine treatment.
    To AC; Looi KL; Damianovich D; Taylor GB; Sidebotham D; White HD
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):725-9. PubMed ID: 18813211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil-induced Tako-Tsubo-like syndrome.
    Basselin C; Fontanges T; Descotes J; Chevalier P; Bui-Xuan B; Feinard G; Timour Q
    Pharmacotherapy; 2011 Feb; 31(2):226. PubMed ID: 21275498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
    Endo A; Yoshida Y; Nakashima R; Takahashi N; Tanabe K
    Int Heart J; 2013; 54(6):417-20. PubMed ID: 24309454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress cardiomyopathy: transient basal ballooning.
    Cacciotti L; Camastra GS; Musarò S; Proietti I; Semeraro R; Martina C; Lupparelli F; Ansalone G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):764-7. PubMed ID: 20093944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
    Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
    Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine and sixth cranial nerve palsy.
    Dasgupta S; Adilieje C; Bhattacharya A; Smith B; Sheikh Mu
    J Cancer Res Ther; 2010; 6(1):80-1. PubMed ID: 20479552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy.
    Klag T; Cantara G; Ong P; Kaufmann M; Sechtem U; Athanasiadis A
    Clin Res Cardiol; 2014 Mar; 103(3):247-50. PubMed ID: 24276117
    [No Abstract]   [Full Text] [Related]  

  • 9. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-induced Takotsubo Cardiomyopathy presenting with cardiogenic shock-utility of extracorporeal membrane oxygenation (ECMO): case report and review of the literature.
    Rojas-Marte G; John J; Sadiq A; Moskovits N; Saunders P; Shani J
    Cardiovasc Revasc Med; 2015; 16(1):47-51. PubMed ID: 25172356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine-associated coronary vasospasm: a case report.
    Papadopoulos CA; Wilson H
    Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine-induced cerebellar toxicity.
    Renouf D; Gill S
    Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine-induced, nonneutropenic enterocolitis.
    Gordon VL; Harding GA; Czaykowski P
    J Gastrointest Cancer; 2011 Dec; 42(4):278-81. PubMed ID: 21243532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reversible cardiogenic shock due to 5FU. Apropos of a case report].
    Dieudonne P; Dumont MA
    Rev Med Brux; 1990 May; 11(5):162-6. PubMed ID: 2353140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-Induced Takotsubo Cardiomyopathy: A Case Report and Literature Review.
    Qasem A; Bin Abdulhak AA; Aly A; Moormeier J
    Am J Ther; 2016; 23(5):e1188-92. PubMed ID: 25549075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversible cardiogenic shock under 5-fluorouracil treatment].
    Bakouboula B; Morel O; Douchet MP; Chauvin M
    Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5 flourouracil-induced apical ballooning syndrome: a case report.
    Gianni M; Dentali F; Lonn E
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):306-8. PubMed ID: 19300240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock with basal transient left ventricular ballooning (Takotsubo-like cardiomyopathy) as first presentation of pheochromocytoma.
    Di Palma G; Daniele GP; Antonini-Canterin F; Piazza R; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):507-10. PubMed ID: 20407387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adderall induced inverted-Takotsubo cardiomyopathy.
    Alsidawi S; Muth J; Wilkin J
    Catheter Cardiovasc Interv; 2011 Nov; 78(6):910-3. PubMed ID: 21567882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.